Current Issue March 2012, Vol. 6, No. 2

Issue Highlights

News from the NLA
March 2012(Vol. 6 | No. 2 | Pages 96-97)
- Full Text
- PDF (118 KB)

Clinical Lipidology Roundtable Discussion

The use of lipopheresis in the practice of clinical lipidology†
March 2012(Vol. 6 | No. 2 | Pages 98-104)
W. Virgil Brown, Robert Brook, Linda C. Hemphill, Patrick M. Moriarty
- Full Text
- PDF (202 KB)

Original Articles

Genotype–phenotype correlation related to lipid profile in beta-thalassemia major and intermedia in southern Iran
March 2012(Vol. 6 | No. 2 | Pages 108-113)
Mohammadreza Bordbar, Sezaneh Haghpanah, Abdolreza Afrasiabi, Javad Dehbozorgian, Mehran Karimi

Phenotypes of Hypertriglyceridemia due to Excess VLDL
01 May 2012
Allan D. Sniderman, Andre Tremblay, Jacqueline De Graaf, Patrick Couture
Abstract: Objective: To characterize the composition of VLDL particles and the proportion of VLDL to total apoB particles in patients with hypertriglyceridemia due to excess VLDL. Methods: Subjects we...
Non–high-density lipoprotein cholesterol reporting and goal attainment in primary care
25 April 2012
Salim S. Virani, Degang Wang, LeChauncy D. Woodard, Supicha S. Chitwood, Cassie R. Landrum, Franklin J. Zieve, Christie M. Ballantyne, Laura A. Petersen
Background: The Adult Treatment Panel III guidelines established non–high-density lipoprotein cholesterol (non-HDL-C) as a secondary treatment target. However, non-HDL-C levels are not reported on sta...
News from the NLA
23 April 2012
On February 28, the U.S. Food and Drug Administration (FDA) approved patient safety label changes for statins. These changes, which are based upon the FDA's comprehensive review of the drug class, are...
Genetic determinants of cardiometabolic risk: A proposed model for phenotype association and interaction
23 April 2012
Piers R. Blackett, Dharambir K. Sanghera
Abstract: This review provides a translational and unifying summary of metabolic syndrome genetics and highlights evidence that genetic studies are starting to unravel and untangle origins of the comp...
From the Editor
16 April 2012
W. Virgil Brown
This issue is published at the time of the National Lipid Association's (NLA) annual meeting in Scottsdale, Arizona. This is a special meeting because it marks the 10th anniversary of the founding of ...

View More Articles in Press...

Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review
January 2012 (Vol. 6 | No. 1 | Pages 5-18)
Terry A. Jacobson, Sara B. Glickstein, Jonathan D. Rowe, Paresh N. Soni
Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men
January 2012 (Vol. 6 | No. 1 | Pages 58-65)
Jennifer G. Robinson, Catherine Rahilly-Tierney, Elizabeth Lawler, J. Michael Gaziano
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
May 2011 (Vol. 5 | No. 3 | Pages 133-140)
Anne C. Goldberg, Paul N. Hopkins, Peter P. Toth, Christie M. Ballantyne, Daniel J. Rader, Jennifer G. Robinson, Stephen R. Daniels, Samuel S. Gidding, Sarah D. de Ferranti, Matthew K. Ito, Mary P. McGowan, Patrick M. Moriarty, William C. Cromwell, Joyce L. Ross, Paul E. Ziajka
Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity
January 2012 (Vol. 6 | No. 1 | Pages 19-26)
Rebecca L. Attridge, William D. Linn, Laurajo Ryan, Jim Koeller, Christopher R. Frei
Lipoprotein (a): Perspectives from a lipid-referral program
January 2012 (Vol. 6 | No. 1 | Pages 66-73)
Melvyn Rubenfire, Deepthi Vodnala, Sangeetha M. Krishnan, Robert L. Bard, Elizabeth A. Jackson, Donald Giacherio, Robert D. Brook

Most Read lists are compiled every quarter.

On the Cover

New Issue Alert

Free Trial Issue

Journal Ranking

Impact Factor:
2010: 1.467
© Thomson Reuters Journal Citation Reports 2011

About Journal of Clinical Lipidology

The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism. The Journal's readership encompasses a broad cross-section of the medical community, including cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity. The Journal also addresses allied health professionals who treat the patient base described above, such as pharmacists, nurse practitioners and dietitians.

Publishing Information

Journal of Clinical Lipidology is published by Elsevier for the National Lipid Association.

Access this journal onSciVerse ScienceDirect

Journal Access

The Journal of Clinical Lipidology is available online. Abstracts and tables of contents are free to all viewers. Full Text is free to NLA members and individual subscribers,as well as to NLA-affiliated organizations. If you are a member of an organizational alliance, you are entitled to take out a complimentary online subscription through December 2013 (online access only). Qualified members interested in this offer should complete this subscription form and e-mail to Elsevier, which will verify eligibility with the NLA. For more information on the NLA's organizational alliance program, please click here

Activate Online Access

CME Multimedia Activities

The Journal of Clinical Lipidology now provides access to peer-reviewed Official Journal CME Multimedia Activities designed to deliver quality education through an interactive experience. This and future CME Multimedia Activities are reviewed by the journal and are found to be educational and of interest to our readership.

NEW! Diagnosis and Management of Familial Hypercholesterolemia in Children and Adults

NEW! Translating HDL Science to Clinical Practice

About the National Lipid Association

The National Lipid Association (NLA) is a non-profit membership association that serves physicians, nurses, pharmacists and dietitians who help manage patients with lipid disorders and cardiovascular disease. The NLA represents more than 2,000 members in the United States and provides continuing medical education for physicians and other healthcare professionals to advance professional development and attain certification in clinical lipidology. The NLA's public health mission is to help reduce deaths related to high cholesterol.